Cure Therapeutics Inc. , New York, N.Y. Business: Musculoskeletal Hired: Ronald Burch as CEO, formerly CEO of AlgoRx Pharmaceuticals Inc.; and Robert Ang as COO, formerly a senior associate at Carrot Capital Healthcare Ventures
WIR Staff...
Basilea (SWX:BSLN) said BAL8557 met the primary endpoint of non-inferiority to fluconazole on endoscopically confirmed clinical cure in a Phase II trial to treat esophageal candidiasis. In the double-blind trial in 160 patients, confirmed clinical...
Cure Therapeutics Inc. , New York, N.Y. Business: Musculoskeletal Hired: Ronald Burch as CEO, formerly CEO of AlgoRx Pharmaceuticals Inc.; and Robert Ang as COO, formerly a senior associate at Carrot Capital Healthcare Ventures
WIR Staff...
Basilea (SWX:BSLN) said BAL8557 met the primary endpoint of non-inferiority to fluconazole on endoscopically confirmed clinical cure in a Phase II trial to treat esophageal candidiasis. In the double-blind trial in 160 patients, confirmed clinical...